{"id":109281,"date":"2024-03-27T15:44:00","date_gmt":"2024-03-27T08:44:00","guid":{"rendered":"https:\/\/www.xinwengao.com\/cn\/pr\/20240327154400109281"},"modified":"2024-03-28T11:46:25","modified_gmt":"2024-03-28T03:46:25","slug":"%e7%bf%b0%e6%a3%ae%e5%88%b6%e8%8d%af2023%e5%b9%b4%e6%80%bb%e8%90%a5%e6%94%b6%e7%a0%b4%e7%99%be%e4%ba%bf-%e5%87%80%e5%88%a9%e6%b6%a6%e5%90%8c%e6%af%94%e5%a2%9e%e9%95%bf26-9","status":"publish","type":"post","link":"https:\/\/www.xinwengao.com\/cn\/pr\/20240327154400109281","title":{"rendered":"\u7ff0\u68ee\u5236\u836f2023\u5e74\u603b\u8425\u6536\u7834\u767e\u4ebf \u51c0\u5229\u6da6\u540c\u6bd4\u589e\u957f26.9%"},"content":{"rendered":"

\u4e0a\u6d77<\/span>2024\u5e743\u670827\u65e5<\/span> \/\u7f8e\u901a\u793e\/ — 2024\u5e743\u670826\u65e5\uff0c\u7ff0\u68ee\u5236\u836f\uff0803692.HK\uff09\u53d1\u5e032023\u5e74\u5ea6\u4e1a\u7ee9\uff0c\u62a5\u544a\u671f\u5185\u5b9e\u73b0\u8425\u4e1a\u6536\u5165\u7ea6\u4eba\u6c11\u5e01101.04\u4ebf\u5143\uff08\u5355\u4f4d\u4e0b\u540c\uff09\uff0c\u8f83\u53bb\u5e74\u540c\u671f\u589e\u957f\u7ea67.7%\uff0c\u51c0\u5229\u6da6\u7ea632.78\u4ebf\u5143\uff0c\u8f83\u53bb\u5e74\u540c\u671f\u589e\u957f\u7ea626.9%\u3002<\/p>\n

\u62a5\u544a\u663e\u793a\uff0c2023\u5e74\u7ff0\u68ee\u5236\u836f\u521b\u65b0\u836f\u4e0e\u5408\u4f5c\u4ea7\u54c1\u6536\u5165\u7ea668.65\u4ebf\u5143\uff0c\u540c\u6bd4\u589e\u957f\u7ea637.1%\uff0c\u5360\u603b\u6536\u5165\u6bd4\u4f8b\u63d0\u5347\u81f367.9%\uff0c\u521b\u65b0\u836f\u5df2\u7ecf\u6210\u4e3a\u9a71\u52a8\u4e1a\u7ee9\u589e\u957f\u7684\u6838\u5fc3\u52a8\u529b\u3002\u9886\u5148\u7684\u521b\u65b0\u5b9e\u529b\u80cc\u540e\u662f\u6301\u7eed\u7684\u7814\u53d1\u6295\u5165\uff0c2023\u5e74\u7ff0\u68ee\u5236\u836f\u7814\u53d1\u5f00\u652f\u7ea6\u4e3a20.97\u4ebf\u5143\uff0c\u540c\u6bd4\u589e\u957f\u7ea623.8%\uff0c\u5360\u603b\u6536\u5165\u6bd4\u4f8b\u589e\u81f320.8%\u3002\u622a\u81f3\u76ee\u524d\uff0c\u516c\u53f8\u5df2\u50a8\u590730\u591a\u4e2a\u521b\u65b0\u836f\u6b63\u5728\u5f00\u5c55\u8d85\u8fc750\u9879\u4e34\u5e8a\uff0c\u7814\u53d1\u52bf\u80fd\u5f3a\u52b2\u3002<\/p>\n

\u5728\u6df1\u8015\u81ea\u4e3b\u7814\u53d1\u7684\u540c\u65f6\uff0c\u7ff0\u68ee\u5236\u836f\u52a0\u901f\u63a8\u8fdb\u5168\u7403\u5408\u4f5c\uff0c\u5728license out\u65b9\u9762\uff0c2023\u5e74\u5206\u522b\u6388\u4e88\u845b\u5170\u7d20\u53f2\u514b\u5f00\u53d1\u53ca\u5546\u4e1a\u5316HS-20089(B7-H4 ADC)\u3001HS-20093(B7-H3 ADC)\u6d77\u5916\u72ec\u5360\u8bb8\u53ef\uff0c\u5145\u5206\u4f53\u73b0\u4e86\u516c\u53f8\u9ad8\u6f5c\u7ba1\u7ebf\u7684\u521b\u65b0\u4ef7\u503c\u3002\u5728license in\u65b9\u9762\uff0c2023\u5e748\u6708\u7ff0\u68ee\u5236\u836f\u4e0e\u5fb7\u742a\u533b\u836f\u7b7e\u8ba2\u534f\u8bae\uff0c\u72ec\u5bb6\u8d1f\u8d23\u585e\u5229\u5c3c\u7d22(selinexor)\u53ca\u4efb\u4f55\u5305\u542b\u6216\u7531\u585e\u5229\u5c3c\u7d22\u7ec4\u6210\u7684\u4ea7\u54c1\uff08\u5546\u54c1\u540d\uff1a\u5e0c\u7ef4\u5965 ) \u5728\u4e2d\u56fd\u5927\u9646\u7684\u5546\u4e1a\u5316\uff1b2024\u5e743\u6708\uff0c\u7ff0\u68ee\u5236\u836f\u4e0e\u666e\u7c73\u65af\u5c31HS-20117\/PM1080\u6269\u5927\u5408\u4f5c\uff0c\u52a0\u7801EGFR\/cMet\u2014ADC\u836f\u7269\u7814\u53d1\uff0c\u6301\u7eed\u5de9\u56fa\u516c\u53f8\u80bf\u7624\u9886\u57df\u4f18\u52bf\u5730\u4f4d\u3002<\/p>\n

\u622a\u81f3\u62a5\u544a\u671f\u672b\uff0c\u7ff0\u68ee\u5236\u836f\u5df2\u7d2f\u8ba1\u5f15\u5165\u4e24\u4e2a\u5728\u5546\u4e1a\u5316\u9636\u6bb5\u7684\u9879\u76ee\uff0c9\u4e2a\u5904\u5728\u4e34\u5e8a\u9636\u6bb5\u7684\u5408\u4f5c\u9879\u76ee\u5df2\u5168\u90e8\u5728\u56fd\u5185\u83b7\u6279\u5f00\u5c55\u4e34\u5e8a\u8bd5\u9a8c\u3002<\/p>\n

\u521b\u65b0\u836f\u4e1a\u7ee9\u518d\u521b\u65b0\u9ad8 \u6253\u9020\u53ef\u6301\u7eed\u589e\u957f\u52a8\u80fd<\/b><\/p>\n

2023\u5e74\uff0c\u7ff0\u68ee\u5236\u836f\u7b2c7\u6b3e\u521b\u65b0\u836f\u5723\u7f57\u83b1\uff08\u57f9\u83ab\u6c99\u80bd\u6ce8\u5c04\u6db2\uff09\u83b7\u6279\u4e0a\u5e02\uff0c\u521b\u65b0\u836f\u4ea7\u54c1\u7ec4\u5408\u8fdb\u4e00\u6b65\u6269\u5bb9\uff0c\u622a\u81f3\u76ee\u524d\uff0c\u516c\u53f87\u6b3e\u5df2\u83b7\u6279\u521b\u65b0\u836f\u5747\u5df2\u88ab\u7eb3\u5165\u56fd\u5bb6\u533b\u4fdd\u76ee\u5f55 \u3002\u51ed\u501f\u591a\u4e2a\u521b\u65b0\u4ea7\u54c1\u9ad8\u4ef7\u503c\u7684\u4e34\u5e8a\u8868\u73b0\u548c\u5dee\u5f02\u5316\u4f18\u52bf\uff0c2023\u5e74\u7ff0\u68ee\u5236\u836f\u6301\u7eed\u63d0\u5347\u8fd0\u8425\u6548\u80fd\uff0c\u7ec4\u7ec7\u67b6\u6784\u9ad8\u6548\u534f\u540c\uff0c\u5168\u9762\u63a8\u8fdb\u4ea7\u54c1\u5546\u4e1a\u5316\uff0c\u516c\u53f8\u521b\u65b0\u836f\u4e0e\u5408\u4f5c\u4ea7\u54c1\u6536\u5165\u7ea668.65\u4ebf\u5143\uff0c\u540c\u6bd4\u589e\u957f\u7ea637.1%\uff0c\u5360\u603b\u6536\u5165\u6bd4\u4f8b\u63d0\u5347\u81f367.9%\u3002<\/p>\n

 \u5206\u9886\u57df\u770b\uff0c2023\u5e74\uff0c\u7ff0\u68ee\u5236\u836f\u5728\u6297\u80bf\u7624\u3001\u6297\u611f\u67d3\u3001\u4e2d\u67a2\u795e\u7ecf\u7cfb\u7edf\u3001\u4ee3\u8c22\u53ca\u5176\u5b83\u75be\u75c5\u9886\u57df\u5206\u522b\u5f55\u5f97  \u6536\u5165\u7ea661.69\u4ebf\u5143\u300112.69\u4ebf\u5143\u300113.67\u4ebf\u5143\u300112.99\u4ebf\u5143\uff0c\u5360\u6536\u5165\u6bd4\u5206\u522b\u7ea6\u4e3a61.0%\u300112.6%\u300113.5%\u300112.9%\u3002<\/p>\n

\u5728\u80bf\u7624\u9886\u57df\uff0c\u7ff0\u68ee\u5236\u836f\u76ee\u524d\u5df2\u4e0a\u5e02\u963f\u7f8e\u4e50\uff08\u7532\u78fa\u9178\u963f\u7f8e\u66ff\u5c3c\u7247\uff09\u4e0e\u8c6a\u68ee\u6615\u798f\uff08\u7532\u78fa\u9178\u6c1f\u9a6c\u66ff\u5c3c\u7247\uff09\u4e24\u6b3e\u81ea\u7814\u521b\u65b0\u4ea7\u54c1\u3002 \u963f\u7f8e\u66ff\u5c3c\u662f\u56fd\u5185\u9996\u4e2a\u81ea\u4e3b\u7814\u53d1\u7684\u4e09\u4ee3EGFR-TKI\uff0c\u5df2\u83b7\u6279\u4e8c\u7ebf\u6cbb\u7597EGFR T790M+\u665a\u671fNSCLC\u3001\u4e00\u7ebf\u6cbb\u7597EGFR+\u665a\u671fNSCLC\u4e24\u4e2a\u9002\u5e94\u75c7\uff0c\u5747\u4e3a\u56fd\u4ea7\u9996\u5bb6\u83b7\u6279\u3002\u56f4\u7ed5\u963f\u7f8e\u66ff\u5c3c\uff0c\u7ff0\u68ee\u5236\u836f\u5168\u9762\u5e03\u5c40\u80ba\u764c\u9886\u57df\uff0c\u6301\u7eed\u5c55\u5f00\u5305\u62ec\u672f\u540e\u8f85\u52a9\uff0c\u4ee5\u53ca\u4e00\u7ebf\u5316\u7597\u8054\u7528\u5728\u5185\u7684\u591a\u4e2a\u9002\u5e94\u75c7\u3002\u76ee\u524d\u963f\u7f8e\u66ff\u5c3c\u591a\u9879\u4e34\u5e8a\u6570\u636e\u90fd\u663e\u793a\u4e86\u4f18\u5f02\u7684\u7597\u6548\uff0c\u5e76\u4f5c\u4e3aI\u7ea7\u6216\u9996\u9009\u63a8\u8350\uff0c\u88ab\u5305\u62ec\u300a\u4e2d\u56fd\u4e34\u5e8a\u80bf\u7624\u5b66\u4f1a\uff08\u300cCSCO\u300d\uff09\u975e\u5c0f\u7ec6\u80de\u80ba\u764c\u8bca\u7597\u6307\u5357\uff082023\u7248\uff09\u300b\u5728\u5185\u76848\u4efd\u56fd\u5bb6\u7ea7\u8bca\u7597\u6307\u5357\u6536\u5f55\u30022023\u5e74\u963f\u7f8e\u4e50\u7684\u53d1\u660e\u4e13\u5229\u300cEGFR \u6291\u5236\u5242\u53ca\u5176\u5236\u5907\u548c\u5e94\u7528\u300d\u4e5f\u8363\u83b7\u7b2c\u4e8c\u5341\u56db\u5c4a\u300c\u4e2d\u56fd\u4e13\u5229\u91d1\u5956\u300d\u3002\u51fa\u6d77\u65b9\u9762\uff0c\u7ff0\u68ee\u5236\u836f\u5c06\u7ee7\u7eed\u63a8\u8fdb\u82f1\u56fd\u836f\u54c1\u548c\u533b\u7597\u4fdd\u5065\u7528\u54c1\u7ba1\u7406\u5c40\uff08\u300cMHRA\u300d\uff09\u53ca\u6b27\u6d32\u836f\u54c1\u7ba1\u7406\u5c40\uff08\u300cEMA\u300d\uff09\u5bf9\u963f\u7f8e\u66ff\u5c3c\u4e0a\u5e02\u8bb8\u53ef\u7533\u8bf7\u5ba1\u8bc4\u7684\u76d1\u7ba1\u7a0b\u5e8f\u3002<\/p>\n

\u6c1f\u9a6c\u66ff\u5c3c\u662f\u9996\u4e2a\u4e2d\u56fd\u539f\u7814\u6162\u6027\u9ad3\u6027\u767d\u8840\u75c5\u65b0\u578b\u4e8c\u4ee3 TKI\uff0c\u7528\u4e8e\u6cbb\u7597\u6162\u6027\u9ad3\u6027\u767d\u8840\u75c5\uff08CML\uff09\u9002\u5e94\u75c7\u3002\u6c1f\u9a6c\u66ff\u5c3c\u5df2\u88ab\u300a\u4e2d\u56fd\u6162\u6027\u9ad3\u6027\u767d\u8840\u75c5\u8bca\u65ad\u4e0e\u6cbb\u7597\u6307\u5357(2020\u7248)\u300b\u53ca\u300aCSCO\u6076\u6027\u8840\u6db2\u75c5\u8bca\u7597\u6307\u5357\u300b\u63a8\u8350\u7528\u4e8e\u6162\u6027\u9ad3\u6027\u767d\u8840\u75c5\u4e00\u7ebf\u6cbb\u7597\u3002<\/p>\n

\u6297\u611f\u67d3\u9886\u57df\uff0c\u7ff0\u68ee\u5236\u836f\u62e5\u6709\u6052\u6c90\uff08\u827e\u7c73\u66ff\u8bfa\u798f\u97e6\u7247\uff09\u548c\u8fc8\u7075\u8fbe (\u5417\u5549\u785d\u5511\u6c2f\u5316\u94a0\u6ce8\u5c04\u6db2\uff09\u4e24\u6b3e\u4e0a\u5e02\u81ea\u7814\u521b\u65b0\u836f\u3002\u6052\u6c90\u662f\u9996\u4e2a\u4e2d\u56fd\u539f\u7814\u53e3\u670d\u6297\u4e59\u578b\u809d\u708e\u75c5\u6bd2\u836f\u7269\uff0c\u5df2\u88ab\u7eb3\u5165\u300aCSCO\u809d\u764c\u8bca\u7597\u6307\u5357\uff082022\u5e74\u7248\uff09\u300b\u5e76\u4f5c\u4e3aI\u7ea7\u63a8\u8350\uff0c\u88ab\u7eb3\u5165\u4e2d\u534e\u533b\u5b66\u4f1a\u809d\u75c5\u5b66\u5206\u4f1a\u548c\u611f\u67d3\u5b66\u5206\u4f1a\u8054\u5408\u53d1\u5e03\u7684\u300a\u6162\u6027\u4e59\u578b\u809d\u708e\u9632\u6cbb\u6307\u5357\uff082022\u5e74\u7248\uff09\u300b\u5e76\u4f5c\u4e3a\u9996\u9009\u836f\u7269\u63a8\u8350\u30022023\u5e74\uff0c\u6052\u6c90 \u2162 \u671f\u5173\u952e\u6ce8\u518c\u4e34\u5e8a\u7814\u7a76\u7684144 \u5468\u6570\u636e\u66f4\u65b0\u5728\u7b2c74\u5c4a\u7f8e\u56fd\u809d\u75c5\u7814\u7a76\u5b66\u4f1a\u5e74\u4f1a\u5165\u9009LBA\u5e76\u53d1\u5e03\uff0c\u7814\u7a76\u7ed3\u679c\u518d\u6b21\u9a8c\u8bc1\u4e86\u957f\u671f\u6cbb\u7597\u6162\u4e59\u809d\u60a3\u8005\u7684\u7597\u6548\u548c\u5b89\u5168\u6027\u3002\u6b64\u5916\uff0c\u6052\u6c90\u2162 \u671f\u5173\u952e\u6ce8\u518c\u4e34\u5e8a\u7814\u7a7648\u5468\u6570\u636e\u53d1\u8868\u5728\u300aAliment Pharmacol Therapeutics\u300b\uff0c96\u5468\u6570\u636e\u53d1\u8868\u5728\u300aJournal of Clinical and Translational Hepatology\u300b\uff0c\u5747\u8bc1\u660e\u4e86\u6052\u6c90\u826f\u597d\u7684\u6297\u4e59\u809d\u75c5\u6bd2\u7597\u6548\u53ca\u9aa8\u3001\u80be\u5b89\u5168\u6027\u3002<\/p>\n

\u4e2d\u67a2\u795e\u7ecf\u7cfb\u7edf\u9886\u57df\uff0c\u7ff0\u68ee\u5236\u836f\u5f15\u8fdb\u7684\u6615\u8d8a\uff08\u4f0a\u5948\u5229\u73e0\u5355\u6297\u6ce8\u5c04\u6db2\uff09\u4e8e2022\u5e74\u83b7\u6279\u4e0a\u5e02\uff0c\u8fd9\u662f\u5168\u7403\u552f\u4e00\u6cbb\u7597AQP4\u6297\u4f53+NMOSD\u7684\u4eba\u6e90\u5316\u6297CD19\u5355\u6297\u3002\u6615\u8d8a\u73b0\u5df2\u88ab\u7eb3\u5165\u300a\u4e2d\u56fd\u89c6\u795e\u7ecf\u810a\u9ad3\u708e\u8c31\u7cfb\u75be\u75c5\u8bca\u65ad\u4e0e\u6cbb\u7597\u6307\u5357(2021\u5e74\u7248)\u300b\uff0c\u5e76\u83b7\u5f97A\u7c7b\u63a8\u8350\u3002\u76ee\u524d\u5408\u4f5c\u65b9\u6b63\u5728\u8fdb\u884cIgG4\u76f8\u5173\u75be\u75c5(IgG4-RD)\u53ca\u91cd\u75c7\u808c\u65e0\u529b (gMG)\u7684\u542b\u4e2d\u56fd\u4e2d\u5fc3\u5728\u5185\u7684\u5168\u7403\u591a\u4e2d\u5fc3\u4e34\u5e8a\u7814\u7a76\u3002<\/p>\n

\u4ee3\u8c22\u53ca\u5176\u5b83\u75be\u75c5\u9886\u57df\uff0c\u7ff0\u68ee\u5236\u836f\u7684\u521b\u65b0\u4ea7\u54c1\u7ec4\u5408\u4e3b\u8981\u5305\u62ec\u5723\u7f57\u83b1\uff08\u57f9\u83ab\u6c99\u80bd\u6ce8\u5c04\u6db2\uff09\u3001\u5b5a\u6765\u7f8e\uff08\u805a\u4e59\u4e8c\u9187\u6d1b\u585e\u90a3\u80bd\u6ce8\u5c04\u6db2\uff09\u3002\u57f9\u83ab\u6c99\u80bd\u662f\u5168\u7403\u552f\u4e00\u83b7\u6279\u4e0a\u5e02\u7684EPO\u6a21\u62df\u80bd \uff0c\u5df2\u83b7\u6279\u9002\u7528\u4e8e\u6cbb\u7597\u56e0\u6162\u6027\u80be\u810f\u75c5\uff08CKD\uff09\u5f15\u8d77\u7684\u8d2b\u8840\uff0c\u5305\u62ec\u672a\u63a5\u53d7\u7ea2\u7ec6\u80de\u751f\u6210\u523a\u6fc0\u5242\uff08ESA\uff09\u6cbb\u7597\u7684\u6210\u4eba\u975e\u900f\u6790\u60a3\u8005\uff0c\u53ca\u6b63\u5728\u63a5\u53d7\u77ed\u6548\u4fc3\u7ea2\u7ec6\u80de\u751f\u6210\u7d20\uff08EPO\uff09\u6cbb\u7597\u7684\u6210\u4eba\u900f\u6790\u60a3\u8005\u30022023\u5e74\uff0c\u5723\u7f57\u83b1\u2162 \u671f\u5173\u952e\u4e34\u5e8a\u8bd5\u9a8c\u6570\u636e\u5728\u300a\u67f3\u53f6\u5200\u300b(The  Lancet)\u5b50\u520a\u300aeClinicalMedicine\u300b\u53d1\u8868\uff0c\u663e\u793a\u51fa\u5176\u4f5c\u4e3aEPO\u53d7\u4f53 \u9ad8\u7279\u5f02\u6027\u6708\u6fc0\u52a8\u5242\uff0c\u76f8\u6bd4\u77ed\u6548ESAs\u836f\u7269\uff0c\u5176\u534a\u8870\u671f\u8f83\u957f\uff0c\u6bcf\u56db\u5468\u7ed9\u836f\u4e00\u6b21\uff0c\u7ed9\u60a3\u8005\u5e26\u6765\u66f4\u591a\u4fbf\u5229\uff0c\u6709\u52a9\u4e8e\u63d0\u9ad8\u6cbb\u7597\u4f9d\u4ece\u6027\u3002<\/p>\n

\u5b5a\u6765\u7f8e\u662f\u56fd\u4ea7\u9996\u6b3e\u539f\u7814\u521b\u65b0\u7684GLP-1RA\u5468\u5236\u5242\uff0c\u4e5f\u662f\u5168\u7403\u7b2c\u4e00\u6b3ePEG\u5316\u7684GLP-1RA\u5468\u5236\u5242\uff0c\u4e3a\u4e2d\u56fd\u7cd6\u5c3f\u75c5\u60a3\u8005\u63d0\u4f9b\u65b0\u7684\u7528\u836f\u9009\u62e9\u3002\u5b5a\u6765\u7f8e\u5df2\u88ab\u7eb3\u5165\u4e2d\u534e\u533b\u5b66\u4f1a\u7cd6\u5c3f\u75c5\u5b66\u5206\u4f1a(CDS)\u53d1\u5e03\u7684\u300a\u4e2d\u56fd2\u578b\u7cd6\u5c3f\u75c5\u9632\u6cbb\u6307\u5357\uff082020\u7248\uff09\u300b\u3002<\/p>\n

\u5dee\u5f02\u5316\u62d3\u5c55\u7814\u53d1\u7ba1\u7ebf \u6df1\u5ea6\u6316\u6398\u4e34\u5e8a\u4ef7\u503c<\/b><\/p>\n

\u9886\u5148\u7684\u836f\u7269\u521b\u65b0\u7814\u53d1\u80fd\u529b\u3001\u79d1\u5b66\u7684\u5f00\u53d1\u7b56\u7565\u548c\u9ad8\u6548\u7684\u6267\u884c\u529b\uff0c\u6b63\u5728\u6210\u4e3a\u7ff0\u68ee\u5236\u836f\u957f\u671f\u53ef\u6301\u7eed\u7ade\u4e89\u529b\u30022023\u5e74\uff0c\u7ff0\u68ee\u5236\u836f\u6301\u7eed\u5f3a\u5316\u81ea\u4e3b\u7814\u53d1\uff0c\u52a0\u901f\u94fe\u63a5\u5168\u7403\u8d44\u6e90\uff0c\u516c\u53f8\u73b0\u5df2\u50a8\u5907\u4e86\u4e00\u7cfb\u5217\u5904\u4e8e\u4e0d\u540c\u7814\u53d1\u9636\u6bb5\u7684\u521b\u65b0\u836f\u7ba1\u7ebf \uff0c\u4e13\u4e1a\u7814\u53d1\u56e2\u961f\u7531\u4f4d\u4e8e\u4e0a\u6d77\u3001\u8fde\u4e91\u6e2f\u548c\u5e38\u5dde\u4ee5\u53ca\u7f8e\u56fd\u9a6c\u91cc\u5170\u5dde\u7684\u56db\u4e2a\u7814\u53d1\u4e2d\u5fc3\u7ea61671\u540d\u7814\u7a76\u4eba\u5458\u7ec4\u6210\uff0c \u6df1\u5165\u62d3\u5c55\u6297\u80bf\u7624\u3001\u6297\u611f\u67d3\u3001\u4e2d\u67a2\u795e\u7ecf\u7cfb\u7edf\u3001\u4ee3\u8c22\u3001\u81ea\u514d\u7b49\u4f18\u52bf\u9886\u57df\u6f5c\u529b\u7ba1\u7ebf\uff0c\u53d6\u5f97\u591a\u9879\u7814\u53d1\u8fdb\u5c55\u3002<\/p>\n

\u6839\u636e\u5e74\u62a5\uff0c\u516c\u53f81\u6b3e\u521b\u65b0\u836f\u827e\u745e\u82ac\u51c0\u7247\uff08Ibrexafungerp\uff09\u4e0a\u5e02\u7533\u8bf7\u83b7\u53d7\u7406\uff1b8\u4e2a1\u7c7b\u521b\u65b0\u836f\u65b0\u589e\u8fdb\u5165\u4e34\u5e8a\u9636\u6bb5\u3002HS-10241\uff08c-MET-TKI\uff09\u3001HS-10365\uff08RET\u6291\u5236\u5242\uff09\u3001HS-20089\uff08B7-H4ADC\uff09\u3001HS-20093\uff08B7-H3 ADC\uff09\u3001HS-10241\uff08GLP-1\/GIP\u53cc\u53d7\u4f53\u6fc0\u52a8\u5242\uff09\u7b49\u591a\u4e2a\u91cd\u70b9\u5728\u7814\u7ba1\u7ebf\uff0c\u4ee5\u53ca\u963f\u7f8e\u66ff\u5c3c\u3001\u6052\u6c90\u3001\u8c6a\u68ee\u6615\u798f\u3001\u5b5a\u6765\u7f8e\u7b49\u521b\u65b0\u4ea7\u54c1\u5747\u53d6\u5f97\u5173\u952e\u7814\u53d1\u8fdb\u5c55\uff0c\u5e76\u4eae\u76f8 ASCO\u3001AACR\u3001ELCC\u3001WCLC\u3001ESMO\u3001ESMO Asia\u3001AASLD\u3001ASH\u3001IDF\u7b49\u5b66\u672f\u5927\u4f1a\uff0c\u6216\u767b\u4e0a\u300a\u67f3\u53f6\u5200\u300b\u5b50\u520a eClinicalMedicine <\/i>\u3001Front. Pharmacol.\u7b49\u56fd\u9645\u6743\u5a01\u533b\u5b66\u671f\u520a\u3002<\/p>\n

\u5207\u5b9e\u8df5\u884c<\/b>ESG\u627f\u8bfa \u59cb\u7ec8\u575a\u5b9a\u8d1f\u8d23\u4efb\u521b\u65b0<\/b><\/p>\n

\u51ed\u501f\u5728\u516c\u53f8\u6cbb\u7406\u3001\u79d1\u7814\u521b\u65b0\u3001\u4eba\u624d\u53d1\u5c55\u3001\u793e\u4f1a\u8d23\u4efb\u3001\u73af\u5883\u4fdd\u62a4\u3001\u4fe1\u606f\u62ab\u9732\u7b49\u8303\u7574\u7684\u5353\u8d8a\u8868\u73b0\uff0c2023\u5e74\uff0c\u7ff0\u68ee\u5236\u836fMSCI\uff08\u660e\u665f\uff09\u8bc4\u7ea7\u8dc3\u5347\u81f3AA\u7ea7\uff0c\u8fbe\u5230\u5168\u7403\u540c\u884c\u9886\u5148\u6c34\u5e73\u3002\u6b64\u5916\u516c\u53f8\u6210\u529f\u5165\u9009\u6807\u666e\u5168\u7403\uff08S&PGlobal\uff09\u300a\u53ef\u6301\u7eed\u53d1\u5c55\u5e74\u9274\uff08\u5168\u7403\u7248\uff092024\u300b\uff0cESG\u8bc4\u5206\u4f4d\u5217\u4e2d\u56fd\u5927\u9646\u5236\u836f\u884c\u4e1a\u7b2c\u4e00\uff1b\u5e76\u5165\u9009\u6807\u666e\u5168\u7403\uff08S&PGlobal\uff09\u9996\u6b21\u53d1\u5e03\u7684\u300a\u53ef\u6301\u7eed\u53d1\u5c55\u5e74\u9274\uff08\u4e2d\u56fd\u7248\uff092023\u300b\uff0c\u4ee5\u5927\u5e45\u9886\u5148\u7684ESG\u8bc4\u5206\u4f4d\u5217\u884c\u4e1a\u6700\u4f731%\uff0c\u83b7\u5f97"\u884c\u4e1a\u6700\u4f73\u8fdb\u6b65\u4f01\u4e1a"\u6b8a\u8363\u3002<\/p>\n","protected":false},"excerpt":{"rendered":"

\u4e0a\u6d772024\u5e743\u670827\u65e5 \/\u7f8e\u901a\u793e\/ — 2024\u5e743\u670826\u65e5\uff0c\u7ff0\u68ee\u5236\u836f\uff0803692.HK\uff09\u53d1\u5e032023\u5e74\u5ea6\u4e1a\u7ee9\uff0c\u62a5\u544a\u671f\u5185\u5b9e\u73b0\u8425\u4e1a\u6536\u5165\u7ea6\u4eba\u6c11\u5e01101.04\u4ebf\u5143\uff08\u5355\u4f4d\u4e0b\u540c\uff09\uff0c\u8f83\u53bb\u5e74\u540c\u671f\u589e\u957f\u7ea67.7%\uff0c\u51c0\u5229\u6da6\u7ea632.78\u4ebf\u5143\uff0c\u8f83\u53bb\u5e74\u540c\u671f\u589e\u957f\u7ea626.9%\u3002 \u62a5\u544a\u663e\u793a\uff0c2023\u5e74\u7ff0\u68ee\u5236\u836f\u521b\u65b0\u836f\u4e0e\u5408\u4f5c\u4ea7\u54c1\u6536\u5165\u7ea668.65\u4ebf\u5143\uff0c\u540c\u6bd4\u589e\u957f\u7ea637.1%\uff0c\u5360\u603b\u6536\u5165\u6bd4\u4f8b\u63d0\u5347\u81f367.9%\uff0c\u521b\u65b0\u836f\u5df2\u7ecf\u6210\u4e3a\u9a71\u52a8\u4e1a\u7ee9\u589e\u957f\u7684\u6838\u5fc3\u52a8\u529b\u3002\u9886\u5148\u7684\u521b\u65b0\u5b9e\u529b\u80cc\u540e\u662f\u6301\u7eed\u7684\u7814\u53d1\u6295\u5165\uff0c2023\u5e74\u7ff0\u68ee\u5236\u836f\u7814\u53d1\u5f00\u652f\u7ea6\u4e3a20.97\u4ebf\u5143\uff0c\u540c\u6bd4\u589e\u957f\u7ea623.8%\uff0c\u5360\u603b\u6536\u5165\u6bd4\u4f8b\u589e\u81f320.8%\u3002\u622a\u81f3\u76ee\u524d\uff0c\u516c\u53f8\u5df2\u50a8\u590730\u591a\u4e2a\u521b\u65b0\u836f\u6b63\u5728\u5f00\u5c55\u8d85\u8fc750\u9879\u4e34\u5e8a\uff0c\u7814\u53d1\u52bf\u80fd\u5f3a\u52b2\u3002 \u5728\u6df1\u8015\u81ea\u4e3b\u7814\u53d1\u7684\u540c\u65f6\uff0c\u7ff0\u68ee\u5236\u836f\u52a0\u901f\u63a8\u8fdb\u5168\u7403\u5408\u4f5c\uff0c\u5728license out\u65b9\u9762\uff0c2023\u5e74\u5206\u522b\u6388\u4e88\u845b\u5170\u7d20\u53f2\u514b\u5f00\u53d1\u53ca\u5546\u4e1a\u5316HS-20089(B7-H4 ADC)\u3001HS-20093(B7-H3 ADC)\u6d77\u5916\u72ec\u5360\u8bb8\u53ef\uff0c\u5145\u5206\u4f53\u73b0\u4e86\u516c\u53f8\u9ad8\u6f5c\u7ba1\u7ebf\u7684\u521b\u65b0\u4ef7\u503c\u3002\u5728license in\u65b9\u9762\uff0c2023\u5e748\u6708\u7ff0\u68ee\u5236\u836f\u4e0e\u5fb7\u742a\u533b\u836f\u7b7e\u8ba2\u534f\u8bae\uff0c\u72ec\u5bb6\u8d1f\u8d23\u585e\u5229\u5c3c\u7d22(selinexor)\u53ca\u4efb\u4f55\u5305\u542b\u6216\u7531\u585e\u5229\u5c3c\u7d22\u7ec4\u6210\u7684\u4ea7\u54c1\uff08\u5546\u54c1\u540d\uff1a\u5e0c\u7ef4\u5965 ) \u5728\u4e2d\u56fd\u5927\u9646\u7684\u5546\u4e1a\u5316\uff1b2024\u5e743\u6708\uff0c\u7ff0\u68ee\u5236\u836f\u4e0e\u666e\u7c73\u65af\u5c31HS-20117\/PM1080\u6269\u5927\u5408\u4f5c\uff0c\u52a0\u7801EGFR\/cMet\u2014ADC\u836f\u7269\u7814\u53d1\uff0c\u6301\u7eed\u5de9\u56fa\u516c\u53f8\u80bf\u7624\u9886\u57df\u4f18\u52bf\u5730\u4f4d\u3002 \u622a\u81f3\u62a5\u544a\u671f\u672b\uff0c\u7ff0\u68ee\u5236\u836f\u5df2\u7d2f\u8ba1\u5f15\u5165\u4e24\u4e2a\u5728\u5546\u4e1a\u5316\u9636\u6bb5\u7684\u9879\u76ee\uff0c9\u4e2a\u5904\u5728\u4e34\u5e8a\u9636\u6bb5\u7684\u5408\u4f5c\u9879\u76ee\u5df2\u5168\u90e8\u5728\u56fd\u5185\u83b7\u6279\u5f00\u5c55\u4e34\u5e8a\u8bd5\u9a8c\u3002 \u521b\u65b0\u836f\u4e1a\u7ee9\u518d\u521b\u65b0\u9ad8 \u6253\u9020\u53ef\u6301\u7eed\u589e\u957f\u52a8\u80fd 2023\u5e74\uff0c\u7ff0\u68ee\u5236\u836f\u7b2c7\u6b3e\u521b\u65b0\u836f\u5723\u7f57\u83b1\uff08\u57f9\u83ab\u6c99\u80bd\u6ce8\u5c04\u6db2\uff09\u83b7\u6279\u4e0a\u5e02\uff0c\u521b\u65b0\u836f\u4ea7\u54c1\u7ec4\u5408\u8fdb\u4e00\u6b65\u6269\u5bb9\uff0c\u622a\u81f3\u76ee\u524d\uff0c\u516c\u53f87\u6b3e\u5df2\u83b7\u6279\u521b\u65b0\u836f\u5747\u5df2\u88ab\u7eb3\u5165\u56fd\u5bb6\u533b\u4fdd\u76ee\u5f55 \u3002\u51ed\u501f\u591a\u4e2a\u521b\u65b0\u4ea7\u54c1\u9ad8\u4ef7\u503c\u7684\u4e34\u5e8a\u8868\u73b0\u548c\u5dee\u5f02\u5316\u4f18\u52bf\uff0c2023\u5e74\u7ff0\u68ee\u5236\u836f\u6301\u7eed\u63d0\u5347\u8fd0\u8425\u6548\u80fd\uff0c\u7ec4\u7ec7\u67b6\u6784\u9ad8\u6548\u534f\u540c\uff0c\u5168\u9762\u63a8\u8fdb\u4ea7\u54c1\u5546\u4e1a\u5316\uff0c\u516c\u53f8\u521b\u65b0\u836f\u4e0e\u5408\u4f5c\u4ea7\u54c1\u6536\u5165\u7ea668.65\u4ebf\u5143\uff0c\u540c\u6bd4\u589e\u957f\u7ea637.1%\uff0c\u5360\u603b\u6536\u5165\u6bd4\u4f8b\u63d0\u5347\u81f367.9%\u3002  \u5206\u9886\u57df\u770b\uff0c2023\u5e74\uff0c\u7ff0\u68ee\u5236\u836f\u5728\u6297\u80bf\u7624\u3001\u6297\u611f\u67d3\u3001\u4e2d\u67a2\u795e\u7ecf\u7cfb\u7edf\u3001\u4ee3\u8c22\u53ca\u5176\u5b83\u75be\u75c5\u9886\u57df\u5206\u522b\u5f55\u5f97  \u6536\u5165\u7ea661.69\u4ebf\u5143\u300112.69\u4ebf\u5143\u300113.67\u4ebf\u5143\u300112.99\u4ebf\u5143\uff0c\u5360\u6536\u5165\u6bd4\u5206\u522b\u7ea6\u4e3a61.0%\u300112.6%\u300113.5%\u300112.9%\u3002 \u5728\u80bf\u7624\u9886\u57df\uff0c\u7ff0\u68ee\u5236\u836f\u76ee\u524d\u5df2\u4e0a\u5e02\u963f\u7f8e\u4e50\uff08\u7532\u78fa\u9178\u963f\u7f8e\u66ff\u5c3c\u7247\uff09\u4e0e\u8c6a\u68ee\u6615\u798f\uff08\u7532\u78fa\u9178\u6c1f\u9a6c\u66ff\u5c3c\u7247\uff09\u4e24\u6b3e\u81ea\u7814\u521b\u65b0\u4ea7\u54c1\u3002 \u963f\u7f8e\u66ff\u5c3c\u662f\u56fd\u5185\u9996\u4e2a\u81ea\u4e3b\u7814\u53d1\u7684\u4e09\u4ee3EGFR-TKI\uff0c\u5df2\u83b7\u6279\u4e8c\u7ebf\u6cbb\u7597EGFR T790M+\u665a\u671fNSCLC\u3001\u4e00\u7ebf\u6cbb\u7597EGFR+\u665a\u671fNSCLC\u4e24\u4e2a\u9002\u5e94\u75c7\uff0c\u5747\u4e3a\u56fd\u4ea7\u9996\u5bb6\u83b7\u6279\u3002\u56f4\u7ed5\u963f\u7f8e\u66ff\u5c3c\uff0c\u7ff0\u68ee\u5236\u836f\u5168\u9762\u5e03\u5c40\u80ba\u764c\u9886\u57df\uff0c\u6301\u7eed\u5c55\u5f00\u5305\u62ec\u672f\u540e\u8f85\u52a9\uff0c\u4ee5\u53ca\u4e00\u7ebf\u5316\u7597\u8054\u7528\u5728\u5185\u7684\u591a\u4e2a\u9002\u5e94\u75c7\u3002\u76ee\u524d\u963f\u7f8e\u66ff\u5c3c\u591a\u9879\u4e34\u5e8a\u6570\u636e\u90fd\u663e\u793a\u4e86\u4f18\u5f02\u7684\u7597\u6548\uff0c\u5e76\u4f5c\u4e3aI\u7ea7\u6216\u9996\u9009\u63a8\u8350\uff0c\u88ab\u5305\u62ec\u300a\u4e2d\u56fd\u4e34\u5e8a\u80bf\u7624\u5b66\u4f1a\uff08\u300cCSCO\u300d\uff09\u975e\u5c0f\u7ec6\u80de\u80ba\u764c\u8bca\u7597\u6307\u5357\uff082023\u7248\uff09\u300b\u5728\u5185\u76848\u4efd\u56fd\u5bb6\u7ea7\u8bca\u7597\u6307\u5357\u6536\u5f55\u30022023\u5e74\u963f\u7f8e\u4e50\u7684\u53d1\u660e\u4e13\u5229\u300cEGFR \u6291\u5236\u5242\u53ca\u5176\u5236\u5907\u548c\u5e94\u7528\u300d\u4e5f\u8363\u83b7\u7b2c\u4e8c\u5341\u56db\u5c4a\u300c\u4e2d\u56fd\u4e13\u5229\u91d1\u5956\u300d\u3002\u51fa\u6d77\u65b9\u9762\uff0c\u7ff0\u68ee\u5236\u836f\u5c06\u7ee7\u7eed\u63a8\u8fdb\u82f1\u56fd\u836f\u54c1\u548c\u533b\u7597\u4fdd\u5065\u7528\u54c1\u7ba1\u7406\u5c40\uff08\u300cMHRA\u300d\uff09\u53ca\u6b27\u6d32\u836f\u54c1\u7ba1\u7406\u5c40\uff08\u300cEMA\u300d\uff09\u5bf9\u963f\u7f8e\u66ff\u5c3c\u4e0a\u5e02\u8bb8\u53ef\u7533\u8bf7\u5ba1\u8bc4\u7684\u76d1\u7ba1\u7a0b\u5e8f\u3002 \u6c1f\u9a6c\u66ff\u5c3c\u662f\u9996\u4e2a\u4e2d\u56fd\u539f\u7814\u6162\u6027\u9ad3\u6027\u767d\u8840\u75c5\u65b0\u578b\u4e8c\u4ee3 TKI\uff0c\u7528\u4e8e\u6cbb\u7597\u6162\u6027\u9ad3\u6027\u767d\u8840\u75c5\uff08CML\uff09\u9002\u5e94\u75c7\u3002\u6c1f\u9a6c\u66ff\u5c3c\u5df2\u88ab\u300a\u4e2d\u56fd\u6162\u6027\u9ad3\u6027\u767d\u8840\u75c5\u8bca\u65ad\u4e0e\u6cbb\u7597\u6307\u5357(2020\u7248)\u300b\u53ca\u300aCSCO\u6076\u6027\u8840\u6db2\u75c5\u8bca\u7597\u6307\u5357\u300b\u63a8\u8350\u7528\u4e8e\u6162\u6027\u9ad3\u6027\u767d\u8840\u75c5\u4e00\u7ebf\u6cbb\u7597\u3002 \u6297\u611f\u67d3\u9886\u57df\uff0c\u7ff0\u68ee\u5236\u836f\u62e5\u6709\u6052\u6c90\uff08\u827e\u7c73\u66ff\u8bfa\u798f\u97e6\u7247\uff09\u548c\u8fc8\u7075\u8fbe (\u5417\u5549\u785d\u5511\u6c2f\u5316\u94a0\u6ce8\u5c04\u6db2\uff09\u4e24\u6b3e\u4e0a\u5e02\u81ea\u7814\u521b\u65b0\u836f\u3002\u6052\u6c90\u662f\u9996\u4e2a\u4e2d\u56fd\u539f\u7814\u53e3\u670d\u6297\u4e59\u578b\u809d\u708e\u75c5\u6bd2\u836f\u7269\uff0c\u5df2\u88ab\u7eb3\u5165\u300aCSCO\u809d\u764c\u8bca\u7597\u6307\u5357\uff082022\u5e74\u7248\uff09\u300b\u5e76\u4f5c\u4e3aI\u7ea7\u63a8\u8350\uff0c\u88ab\u7eb3\u5165\u4e2d\u534e\u533b\u5b66\u4f1a\u809d\u75c5\u5b66\u5206\u4f1a\u548c\u611f\u67d3\u5b66\u5206\u4f1a\u8054\u5408\u53d1\u5e03\u7684\u300a\u6162\u6027\u4e59\u578b\u809d\u708e\u9632\u6cbb\u6307\u5357\uff082022\u5e74\u7248\uff09\u300b\u5e76\u4f5c\u4e3a\u9996\u9009\u836f\u7269\u63a8\u8350\u30022023\u5e74\uff0c\u6052\u6c90 \u2162 \u671f\u5173\u952e\u6ce8\u518c\u4e34\u5e8a\u7814\u7a76\u7684144 \u5468\u6570\u636e\u66f4\u65b0\u5728\u7b2c74\u5c4a\u7f8e\u56fd\u809d\u75c5\u7814\u7a76\u5b66\u4f1a\u5e74\u4f1a\u5165\u9009LBA\u5e76\u53d1\u5e03\uff0c\u7814\u7a76\u7ed3\u679c\u518d\u6b21\u9a8c\u8bc1\u4e86\u957f\u671f\u6cbb\u7597\u6162\u4e59\u809d\u60a3\u8005\u7684\u7597\u6548\u548c\u5b89\u5168\u6027\u3002\u6b64\u5916\uff0c\u6052\u6c90\u2162 \u671f\u5173\u952e\u6ce8\u518c\u4e34\u5e8a\u7814\u7a7648\u5468\u6570\u636e\u53d1\u8868\u5728\u300aAliment Pharmacol Therapeutics\u300b\uff0c96\u5468\u6570\u636e\u53d1\u8868\u5728\u300aJournal of Clinical and Translational Hepatology\u300b\uff0c\u5747\u8bc1\u660e\u4e86\u6052\u6c90\u826f\u597d\u7684\u6297\u4e59\u809d\u75c5\u6bd2\u7597\u6548\u53ca\u9aa8\u3001\u80be\u5b89\u5168\u6027\u3002 \u4e2d\u67a2\u795e\u7ecf\u7cfb\u7edf\u9886\u57df\uff0c\u7ff0\u68ee\u5236\u836f\u5f15\u8fdb\u7684\u6615\u8d8a\uff08\u4f0a\u5948\u5229\u73e0\u5355\u6297\u6ce8\u5c04\u6db2\uff09\u4e8e2022\u5e74\u83b7\u6279\u4e0a\u5e02\uff0c\u8fd9\u662f\u5168\u7403\u552f\u4e00\u6cbb\u7597AQP4\u6297\u4f53+NMOSD\u7684\u4eba\u6e90\u5316\u6297CD19\u5355\u6297\u3002\u6615\u8d8a\u73b0\u5df2\u88ab\u7eb3\u5165\u300a\u4e2d\u56fd\u89c6\u795e\u7ecf\u810a\u9ad3\u708e\u8c31\u7cfb\u75be\u75c5\u8bca\u65ad\u4e0e\u6cbb\u7597\u6307\u5357(2021\u5e74\u7248)\u300b\uff0c\u5e76\u83b7\u5f97A\u7c7b\u63a8\u8350\u3002\u76ee\u524d\u5408\u4f5c\u65b9\u6b63\u5728\u8fdb\u884cIgG4\u76f8\u5173\u75be\u75c5(IgG4-RD)\u53ca\u91cd\u75c7\u808c\u65e0\u529b (gMG)\u7684\u542b\u4e2d\u56fd\u4e2d\u5fc3\u5728\u5185\u7684\u5168\u7403\u591a\u4e2d\u5fc3\u4e34\u5e8a\u7814\u7a76\u3002 \u4ee3\u8c22\u53ca\u5176\u5b83\u75be\u75c5\u9886\u57df\uff0c\u7ff0\u68ee\u5236\u836f\u7684\u521b\u65b0\u4ea7\u54c1\u7ec4\u5408\u4e3b\u8981\u5305\u62ec\u5723\u7f57\u83b1\uff08\u57f9\u83ab\u6c99\u80bd\u6ce8\u5c04\u6db2\uff09\u3001\u5b5a\u6765\u7f8e\uff08\u805a\u4e59\u4e8c\u9187\u6d1b\u585e\u90a3\u80bd\u6ce8\u5c04\u6db2\uff09\u3002\u57f9\u83ab\u6c99\u80bd\u662f\u5168\u7403\u552f\u4e00\u83b7\u6279\u4e0a\u5e02\u7684EPO\u6a21\u62df\u80bd \uff0c\u5df2\u83b7\u6279\u9002\u7528\u4e8e\u6cbb\u7597\u56e0\u6162\u6027\u80be\u810f\u75c5\uff08CKD\uff09\u5f15\u8d77\u7684\u8d2b\u8840\uff0c\u5305\u62ec\u672a\u63a5\u53d7\u7ea2\u7ec6\u80de\u751f\u6210\u523a\u6fc0\u5242\uff08ESA\uff09\u6cbb\u7597\u7684\u6210\u4eba\u975e\u900f\u6790\u60a3\u8005\uff0c\u53ca\u6b63\u5728\u63a5\u53d7\u77ed\u6548\u4fc3\u7ea2\u7ec6\u80de\u751f\u6210\u7d20\uff08EPO\uff09\u6cbb\u7597\u7684\u6210\u4eba\u900f\u6790\u60a3\u8005\u30022023\u5e74\uff0c\u5723\u7f57\u83b1\u2162 \u671f\u5173\u952e\u4e34\u5e8a\u8bd5\u9a8c\u6570\u636e\u5728\u300a\u67f3\u53f6\u5200\u300b(The  Lancet)\u5b50\u520a\u300aeClinicalMedicine\u300b\u53d1\u8868\uff0c\u663e\u793a\u51fa\u5176\u4f5c\u4e3aEPO\u53d7\u4f53 \u9ad8\u7279\u5f02\u6027\u6708\u6fc0\u52a8\u5242\uff0c\u76f8\u6bd4\u77ed\u6548ESAs\u836f\u7269\uff0c\u5176\u534a\u8870\u671f\u8f83\u957f\uff0c\u6bcf\u56db\u5468\u7ed9\u836f\u4e00\u6b21\uff0c\u7ed9\u60a3\u8005\u5e26\u6765\u66f4\u591a\u4fbf\u5229\uff0c\u6709\u52a9\u4e8e\u63d0\u9ad8\u6cbb\u7597\u4f9d\u4ece\u6027\u3002 \u5b5a\u6765\u7f8e\u662f\u56fd\u4ea7\u9996\u6b3e\u539f\u7814\u521b\u65b0\u7684GLP-1RA\u5468\u5236\u5242\uff0c\u4e5f\u662f\u5168\u7403\u7b2c\u4e00\u6b3ePEG\u5316\u7684GLP-1RA\u5468\u5236\u5242\uff0c\u4e3a\u4e2d\u56fd\u7cd6\u5c3f\u75c5\u60a3\u8005\u63d0\u4f9b\u65b0\u7684\u7528\u836f\u9009\u62e9\u3002\u5b5a\u6765\u7f8e\u5df2\u88ab\u7eb3\u5165\u4e2d\u534e\u533b\u5b66\u4f1a\u7cd6\u5c3f\u75c5\u5b66\u5206\u4f1a(CDS)\u53d1\u5e03\u7684\u300a\u4e2d\u56fd2\u578b\u7cd6\u5c3f\u75c5\u9632\u6cbb\u6307\u5357\uff082020\u7248\uff09\u300b\u3002 \u5dee\u5f02\u5316\u62d3\u5c55\u7814\u53d1\u7ba1\u7ebf \u6df1\u5ea6\u6316\u6398\u4e34\u5e8a\u4ef7\u503c \u9886\u5148\u7684\u836f\u7269\u521b\u65b0\u7814\u53d1\u80fd\u529b\u3001\u79d1\u5b66\u7684\u5f00\u53d1\u7b56\u7565\u548c\u9ad8\u6548\u7684\u6267\u884c\u529b\uff0c\u6b63\u5728\u6210\u4e3a\u7ff0\u68ee\u5236\u836f\u957f\u671f\u53ef\u6301\u7eed\u7ade\u4e89\u529b\u30022023\u5e74\uff0c\u7ff0\u68ee\u5236\u836f\u6301\u7eed\u5f3a\u5316\u81ea\u4e3b\u7814\u53d1\uff0c\u52a0\u901f\u94fe\u63a5\u5168\u7403\u8d44\u6e90\uff0c\u516c\u53f8\u73b0\u5df2\u50a8\u5907\u4e86\u4e00\u7cfb\u5217\u5904\u4e8e\u4e0d\u540c\u7814\u53d1\u9636\u6bb5\u7684\u521b\u65b0\u836f\u7ba1\u7ebf \uff0c\u4e13\u4e1a\u7814\u53d1\u56e2\u961f\u7531\u4f4d\u4e8e\u4e0a\u6d77\u3001\u8fde\u4e91\u6e2f\u548c\u5e38\u5dde\u4ee5\u53ca\u7f8e\u56fd\u9a6c\u91cc\u5170\u5dde\u7684\u56db\u4e2a\u7814\u53d1\u4e2d\u5fc3\u7ea61671\u540d\u7814\u7a76\u4eba\u5458\u7ec4\u6210\uff0c \u6df1\u5165\u62d3\u5c55\u6297\u80bf\u7624\u3001\u6297\u611f\u67d3\u3001\u4e2d\u67a2\u795e\u7ecf\u7cfb\u7edf\u3001\u4ee3\u8c22\u3001\u81ea\u514d\u7b49\u4f18\u52bf\u9886\u57df\u6f5c\u529b\u7ba1\u7ebf\uff0c\u53d6\u5f97\u591a\u9879\u7814\u53d1\u8fdb\u5c55\u3002 \u6839\u636e\u5e74\u62a5\uff0c\u516c\u53f81\u6b3e\u521b\u65b0\u836f\u827e\u745e\u82ac\u51c0\u7247\uff08Ibrexafungerp\uff09\u4e0a\u5e02\u7533\u8bf7\u83b7\u53d7\u7406\uff1b8\u4e2a1\u7c7b\u521b\u65b0\u836f\u65b0\u589e\u8fdb\u5165\u4e34\u5e8a\u9636\u6bb5\u3002HS-10241\uff08c-MET-TKI\uff09\u3001HS-10365\uff08RET\u6291\u5236\u5242\uff09\u3001HS-20089\uff08B7-H4ADC\uff09\u3001HS-20093\uff08B7-H3 ADC\uff09\u3001HS-10241\uff08GLP-1\/GIP\u53cc\u53d7\u4f53\u6fc0\u52a8\u5242\uff09\u7b49\u591a\u4e2a\u91cd\u70b9\u5728\u7814\u7ba1\u7ebf\uff0c\u4ee5\u53ca\u963f\u7f8e\u66ff\u5c3c\u3001\u6052\u6c90\u3001\u8c6a\u68ee\u6615\u798f\u3001\u5b5a\u6765\u7f8e\u7b49\u521b\u65b0\u4ea7\u54c1\u5747\u53d6\u5f97\u5173\u952e\u7814\u53d1\u8fdb\u5c55\uff0c\u5e76\u4eae\u76f8 ASCO\u3001AACR\u3001ELCC\u3001WCLC\u3001ESMO\u3001ESMO Asia\u3001AASLD\u3001ASH\u3001IDF\u7b49\u5b66\u672f\u5927\u4f1a\uff0c\u6216\u767b\u4e0a\u300a\u67f3\u53f6\u5200\u300b\u5b50\u520a eClinicalMedicine \u3001Front. Pharmacol.\u7b49\u56fd\u9645\u6743\u5a01\u533b\u5b66\u671f\u520a\u3002 \u5207\u5b9e\u8df5\u884cESG\u627f\u8bfa \u59cb\u7ec8\u575a\u5b9a\u8d1f\u8d23\u4efb\u521b\u65b0 \u51ed\u501f\u5728\u516c\u53f8\u6cbb\u7406\u3001\u79d1\u7814\u521b\u65b0\u3001\u4eba\u624d\u53d1\u5c55\u3001\u793e\u4f1a\u8d23\u4efb\u3001\u73af\u5883\u4fdd\u62a4\u3001\u4fe1\u606f\u62ab\u9732\u7b49\u8303\u7574\u7684\u5353\u8d8a\u8868\u73b0\uff0c2023\u5e74\uff0c\u7ff0\u68ee\u5236\u836fMSCI\uff08\u660e\u665f\uff09\u8bc4\u7ea7\u8dc3\u5347\u81f3AA\u7ea7\uff0c\u8fbe\u5230\u5168\u7403\u540c\u884c\u9886\u5148\u6c34\u5e73\u3002\u6b64\u5916\u516c\u53f8\u6210\u529f\u5165\u9009\u6807\u666e\u5168\u7403\uff08S&PGlobal\uff09\u300a\u53ef\u6301\u7eed\u53d1\u5c55\u5e74\u9274\uff08\u5168\u7403\u7248\uff092024\u300b\uff0cESG\u8bc4\u5206\u4f4d\u5217\u4e2d\u56fd\u5927\u9646\u5236\u836f\u884c\u4e1a\u7b2c\u4e00\uff1b\u5e76\u5165\u9009\u6807\u666e\u5168\u7403\uff08S&PGlobal\uff09\u9996\u6b21\u53d1\u5e03\u7684\u300a\u53ef\u6301\u7eed\u53d1\u5c55\u5e74\u9274\uff08\u4e2d\u56fd\u7248\uff092023\u300b\uff0c\u4ee5\u5927\u5e45\u9886\u5148\u7684ESG\u8bc4\u5206\u4f4d\u5217\u884c\u4e1a\u6700\u4f731%\uff0c\u83b7\u5f97"\u884c\u4e1a\u6700\u4f73\u8fdb\u6b65\u4f01\u4e1a"\u6b8a\u8363\u3002… Read More<\/a><\/p>\n","protected":false},"author":556,"featured_media":0,"comment_status":"close","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1965],"tags":[],"class_list":["post-109281","post","type-post","status-publish","format-standard","hentry","category-partnerships"],"amp_enabled":true,"_links":{"self":[{"href":"https:\/\/www.xinwengao.com\/cn\/wp-json\/wp\/v2\/posts\/109281","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.xinwengao.com\/cn\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.xinwengao.com\/cn\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.xinwengao.com\/cn\/wp-json\/wp\/v2\/users\/556"}],"replies":[{"embeddable":true,"href":"https:\/\/www.xinwengao.com\/cn\/wp-json\/wp\/v2\/comments?post=109281"}],"version-history":[{"count":1,"href":"https:\/\/www.xinwengao.com\/cn\/wp-json\/wp\/v2\/posts\/109281\/revisions"}],"predecessor-version":[{"id":109282,"href":"https:\/\/www.xinwengao.com\/cn\/wp-json\/wp\/v2\/posts\/109281\/revisions\/109282"}],"wp:attachment":[{"href":"https:\/\/www.xinwengao.com\/cn\/wp-json\/wp\/v2\/media?parent=109281"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.xinwengao.com\/cn\/wp-json\/wp\/v2\/categories?post=109281"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.xinwengao.com\/cn\/wp-json\/wp\/v2\/tags?post=109281"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}